Due to the broad substrate scope, NQO1 can activate chemotherapeutic prodrugs, such as mitomycin C and β‐lapachone, and since the level of NQO1 is increased in several tumors, the quinone‐based chemotherapeutic activity will be specifically observed on the tumor cells 4, 5, 6. This evidence concerns the gene NQO1 and neoplasm.